https://clarivate.com/life-sciences-healthcare/report/dlsfon0016-2018-biopharma-acute-myeloid-leukemia-disease-landscape-and-forecast-g7-2018/
Acute Myeloid Leukemia | Disease Landscape and Forecast | G7 | 2018 | Clarivate
Acute myeloid leukemia (AML) is the most common form of adult leukemia and has the lowest five-year overall survival rates of all blood cancers. Historically,...
acute myeloid leukemiag7 2018diseaselandscapeforecast
https://clarivate.com/life-sciences-healthcare/report/dlsfim0006-2018-biopharma-psoriatic-arthritis-disease-landscape-and-forecast-g7-2018/
Psoriatic Arthritis | Disease Landscape and Forecast | G7 | 2018 | Clarivate
PsA, a disease characterized by flaky psoriatic skin lesions, erosive joint damage, and complicating comorbidities, remains poorly understood, underdiagnosed,...
psoriatic arthritisg7 2018diseaselandscapeforecast
https://clarivate.com/life-sciences-healthcare/report/dlsfim0002-2018-biopharma-axial-spondyloarthritis-disease-landscape-and-forecast-g7-2018/
Axial Spondyloarthritis | Disease Landscape and Forecast | G7 | 2018 | Clarivate
The treatment of axial spondyloarthritis has been transformed in the last decade by the approval of biologics to treat the disease and the recognition that...
axial spondyloarthritisg7 2018diseaselandscapeforecast
https://clarivate.com/life-sciences-healthcare/report/dlsfon0002-2018-biopharma-colorectal-cancer-disease-landscape-and-forecast-g7-2018/
Colorectal Cancer | Disease Landscape and Forecast | G7 | 2018 | Clarivate
Colorectal cancer is the third-most-common cancer globally and is associated with a five-year overall survival of 65.1%. Current treatment for metastatic...
colorectal cancerg7 2018diseaselandscapeforecast
https://sputnikglobe.com/20180614/trump-russia-g7-summit-1065388052.html
G7 Leaders Spent 25% of Summit Talking About Russia, Trump Says - 14.06.2018, Sputnik International
WASHINGTON (Sputnik) - US President Donald Trump in an interview said Russia should be readmitted into the G7 considering its members discussed issues...